Filing Details

Accession Number:
0001213900-20-044061
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-22 16:03:19
Reporting Period:
2020-12-18
Accepted Time:
2020-12-22 16:03:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1522602 Cohbar Inc. CWBR Pharmaceutical Preparations (2834) 261299952
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1627971 Francis Jeffrey Biunno C/O Cohbar, Inc.
1455 Adams Drive, Suite 2050
Menlo Park CA 94025
Cfo, Treasurer And Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-12-18 7,490 $0.00 17,490 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrants (Right to buy) Acquisiton 2020-12-18 5,618 $0.00 5,618 $1.44
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,618 2021-06-18 2026-06-18 No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,000 Indirect By daughter
Footnotes
  1. The reported securities are included within Units purchased by the Reporting Person for $1.22 per Unit upon conversion of a Promissory Note held by the Reporting Person. Each Unit consists of one share of the Issuer's common stock and one warrant to purchase 0.75 of one share of the Issuer's common stock at an exercise price of $1.44.
  2. Consists of previously reported shares indirectly beneficially owned by the Reporting Person.